Table 3.
Frequently cited references in HNC and oral sex
| Cited references | Citations |
|---|---|
| D’souza g., kreimer a.r., viscidi r., et al., case-control study of human papillomavirus and oropharyngeal cancer, n engl j med, 356, pp. 1944–1956, (2007) | 94 |
| Kreimer a.r., clifford g.m., boyle p., franceschi s., human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review, cancer epidemiol biomarkers prev, 14, pp. 467–475, (2005) | 93 |
| Chaturvedi a.k., engels e.a., pfeiffer r.m., et al., human papillomavirus and rising oropharyngeal cancer incidence in the United States, j clin oncol, 29, pp. 4294–4301, (2011) | 90 |
| Gillison m.l., koch w.m., capone r.b., et al., evidence for a causal association between human papillomavirus and a subset of head and neck cancers, j natl cancer inst, 92, pp. 709–720, (2000) | 90 |
| Ang k.k., harris j., wheeler r., et al., human papillomavirus and survival of patients with oropharyngeal cancer, n engl j med, 363, pp. 24–35, (2010) | 79 |
| D’souza g., agrawal y., halpern j., bodison s., gillison m.l., oral sexual behaviors associated with prevalent oral human papillomavirus infection, j infect dis, 199, pp. 1263–1269, (2009) | 75 |
| Gillison m.l., d’souza g., westra w., et al., distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers, j natl cancer inst, 100, pp. 407–420, (2008) | 65 |
| Chaturvedi a.k., engels e.a., anderson w.f., gillison m.l., incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States, j clin oncol, 26, pp. 612–619, (2008) | 63 |
| Herrero r., castellsague x., pawlita m., et al., human papillomavirus and oral cancer: the international agency for research on cancer multicenter study, j natl cancer inst, 95, pp. 1772–1783, (2003) | 60 |
| Fakhry c., westra w.h., li s., et al., improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial, j natl cancer inst, 100, pp. 261–269, (2008) | 57 |